Stroke was predicted by dimensions of quality of life in treated hypertensive men

Stroke

Volumn 29, Issue 11, 1998, Pages 2329-2333

  Agewall, Stefan ^b   Wikstrand, John ^a,b   Fagerberg, Björn ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Psychiatric status rating scales; Quality of life; Risk factors; Social support; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; STROKE; WELLBEING;

EID: 0031729778     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.11.2329     Document Type: Article

References (30)

1. Manuck SB, Kaplan JR, Matthews KA. Behavioral antecedents of coronary heart disease and atherosclerosis. Arteriosclerosis. 1986;6:1-14.
2. Kaplan JR, Adams MR, Anthony MS, Morgan TM, Manuck SB, Clarkson TB. Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Arterioscler Thormb Vasc Biol. 1995;15:2094-2100.
3. Haynes SG, Feinleib M, Kannel WB. The relationship of psychosocial factors to coronary heart disease in the Framingham Study, III: eight-year incidence of coronary heart disease. Am J Epidemiol. 1983;111:37-58.
4. Jenkins CD, Rosenman RH, Zyzanski SJ. Prediction of clinical coronary heart disease by a test for the coronary-prone behavior pattern. N Engl J Med. 1974;290:1271-1275.
5. Case RB, Heller SS, Case NB, Moss AJ. Type A behavior and survival after acute myocardial infarction. N Engl J Med. 1985;312:737-741.
6. Shekelle RB, Hulley SB, Neaton JD, Billings JH, Borhani NO, Gerace TA, Jacobs DR, Lasser-NL, Mittlemark MB, Stamler J. The MRFIT behavior pattern study, II: type A behavior and incidence of coronary heart disease. Am J Epidemiol. 1985;122:559-570.
7. Marmot MG. Stress, social and cultural variations in heart disease. J Psychosom Res. 1983;27:377-384.
8. Reed D, McGee D, Yano Y, Feinleib M. Social networks and coronary heart disease among Japanese men in Hawaii. Am J Epidemiol. 1983;117: 384-396.
9. Berkman LF, Syme SL. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol. 1979;109:186-204.
10. Matsumoto Y, Uyama O, Shimizu S, Michishita H, Mori R, Owada T, Sugita M. Do anger and aggression affect carotid atherosclerosis? Stroke. 1993;24:983-986.
11. Welin L, Tibblin G, Svärdsudd K, Tibblin B, Ander-Peciva S, Larsson B, Wilhelmsen L. Prospective study of social influences on mortality: the study of men born in 1913 and 1923. Lancet. 1985;1:915-918.
12. Rabins PV, Harvis DJ, Koven S. High fatality rates of late life depression associated with cardiovascular disease. J Affect Disord. 1985;241:540-545.
13. Colantonio A, Kasi SV, Ostfeld AM. Depressive symptoms and other social factors as predictors of stroke in the elderly. Am J Epidemiol. 1992;136:884-895.
14. Agewall S, Wikstrand J, Dahlöf C, Fagerberg B. Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk. Am J Hypertens. 1996;9:545-550.
15. Agewall S, Samuelsson O, Andersson OK, Persson B, Wikstrand J, Fagerberg B. The efficacy of multiple risk factor intervention in treated hypertensive men, during long term follow-up. J Intern Med. 1994;236: 651-659.
16. WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, Switzerland: WHO; 1980. Technical Report Series, No. 646.
17. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, Vedin A, Wilhelmsson C, Werkö L. The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J. 1986;7:279-288.
18. Fagerberg B, Wikstrand J, Berglund G, Samuelsson O, Agewall S. Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced: a randomized intervention study. Am J Hypertens. 1998;11:14-22.
19. Dahlöf C, Dimenäs E, Olofsson B. Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy. Cardiovasc Drug Ther. 1989;3:919-927.
20. Dahlöf C. Minor symptoms evaluation (MSE) profile: a questionnaire for assessment of subjective CNS-related symptoms. Scand J Prim Health Care. 1990;1(suppl):19-25.
21. Dimenäs E, Wiklund I, Dahlöf C, Lindvall KG, Olofsson B, de Faire U. Differences in the subjective well-being and symptoms of normotensives, borderline hypertensives and hypertensives. J Hypertens. 1989;7:885-890.
22. Lynch J, Kaplan GA, Salonen R, Cohen RD, Salonen JT. Socioeconomic status and carotid atherosclerosis. Circulation. 1995;92:1786-1792.
23. Everson SA, Lynch JW, Chesney MA. Interaction of workplace demands and cardiovascular reactivity in progression of carotid atherosclerosis: population based study. BMJ. 1997;314:553-558.
24. Everson SA, Goldberg DE, Kaplan GA, Cohen RD, Pukkala E, Tuomilehto J, Salonen JT. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med. 1996;58:113-121.
25. Strawn WB, Bondgers G, Kaplan JR, Manuck SB, Schwenke DC, Hanson GK, Shivley CA, Clarkson TB. Endothelial dysfunction in response to psychosocial stress in monkeys. Circ Res. 1991;68:1270-1279.
26. Kaplan JR, Manuck SB, Adams MR, Weingard KW, Clarkson TB. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed with an atherogenic diet. Circulation. 1987;76:1364-1372.
27. Petterson K, Bejne B, Bjorl H, Strawn WB, Bondgers G. Experimental sympathetic activation causes endothelial injury in the rabbit thoracic aorta via β1-adrenoreceptor activation. Circ Res. 1990;67:1027-1034.
28. Hilgers KF, Veelken R, Kreppner I, Ganten D, Luft FC, Geiger H, Mann JFE. Vascular angiotensin and the sympathetic nervous system: do they interact? Am J Physiol. 1994;267:H187-H194.
29. Åberg G, Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol. 1990;15(suppl 5):S65-S72.
30. Jern C, Selin L, Jern S. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress. Thromb Haemost. 1994;72:285-291.